An overview of nanostructured lipid carriers and its application in drug delivery through different routes

255Citations
Citations of this article
840Readers
Mendeley users who have this article in their library.

Abstract

Nanostructured lipid carriers (NLCs) are nano-sized colloidal drug delivery system that contains a lipid mixture consisting of both solid and liquid lipids in their core. This lipid-based nanosystem is introduced as a biocompatible, non-Toxic, and safe nano-drug delivery system as compared to polymeric or metallic nanoparticles. Due to its safety, stability, and high drug loading capacity compared to other lipid-based nanocarriers, NLC gained the attention of researchers to formulate safe and effective drug carriers. The ability to increase drug solubility and permeability while encapsulating the drug in a lipidic shell makes them an ideal carrier for drug delivery through difficult-To-Achieve routes. Surface modification of NLC and the use of various additives result in drug targeting and increased residence time. With such qualities, NLCs can be used to treat a variety of diseases such as cancer, infections, neurodegenerative diseases, hypertension, diabetes, and pain management. This review focuses on the recent developments being made to deliver the drugs and genes through different routes via these nanocarriers. Here, we also discuss about historical background, structure, types of NLC and commonly employed techniques for manufacturing lipid-based nanocarriers.

Cite

CITATION STYLE

APA

Khan, S., Sharma, A., & Jain, V. (2023). An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Advanced Pharmaceutical Bulletin. Tabriz University of Medical Sciences. https://doi.org/10.34172/apb.2023.056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free